The utility of HTS TCR analyses in the management of patients with T-cell malignancies.
Ilan Lanny Kirsch
Stock Ownership - Adaptive Biotechnologies
Anna Sherwood
Stock Ownership - Adaptive Biotechnologies
David Williamson
Stock Ownership - Adaptive Biotechnologies
Wen-Kai Weng
No relevant relationships to disclose
Rachael Clark
No relevant relationships to disclose
Thomas Seth Kupper
No relevant relationships to disclose
David Wu
No relevant relationships to disclose
Harlan Robins
Stock Ownership - Adaptive Biotechnologies (B)